.Merely 5 months after protecting a $100 million IPO, Limitless Bio is currently giving up some empl...
.The initial stages of oncology R&D may not be short of appealing brand new methods, and also Hal...
.Psychopharmacology has actually pulled three posts about midstage professional test data evaluating...
.Avidity Biosciences amazed financiers with stage 1/2 data in Duchenne muscular dystrophy (DMD) Frid...
.Actinogen Medical's cortisol blocker has actually missed the key endpoint of a period 2 research in...
.Antibody-drug conjugates (ADCs) have been at the center of lots of a billion-dollar biobuck licensi...
.Resource supervisor TPG, which has supported biotechs including Sionna Therapies and Santa Ana Bio,...
.Merck & Co.'s TIGIT program has actually gone through an additional drawback. Months after shutt...
.After a year determined by pipeline hairstyles, the variation of its own chief executive officer an...
.Cullinan Therapy was actually excited enough with Harbour BioMed's bispecific invulnerable reactor ...